Hangzhou AGS MedTech Co. Ltd. A Cash Flow Reinvestment Rate
Hangzhou AGS MedTech Co. Ltd. A cash flow reinvestment rate. Hangzhou AGS MedTech Co. Ltd. A (688581) has a Cash Flow Reinvestment Rate of 0.42x as of December 2025, reinvesting CN¥63.47 Million (capex CN¥63.47 Million ) from operating cash flow of CN¥151.20 Million. Explore Hangzhou AGS MedTech Co. Ltd. A debt service capacity to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Hangzhou AGS MedTech Co. Ltd. A (2021–2025)
Cash flow reinvestment rate of Hangzhou AGS MedTech Co. Ltd. A from 2021 to 2025. Historical reinvestment intensity for Hangzhou AGS MedTech Co. Ltd. A across 5 annual periods. Explore how much does Hangzhou AGS MedTech Co. Ltd. A reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Hangzhou AGS MedTech Co. Ltd. A Cash Flow Reinvestment Rate by Year (2021–2025)
Hangzhou AGS MedTech Co. Ltd. A cash flow reinvestment rate by year from 2021 to 2025. Year-by-year capital reinvestment analysis for Hangzhou AGS MedTech Co. Ltd. A. For the full cash flow conversion analysis, see 688581 cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.42x | CN¥63.47 Million | CN¥151.20 Million | CN¥63.47 Million | ▲ +167.2% |
| 2024 | 0.16x | CN¥49.60 Million | CN¥315.80 Million | CN¥49.60 Million | ▼ -32.6% |
| 2023 | 0.23x | CN¥51.57 Million | CN¥221.45 Million | CN¥51.57 Million | ▼ -39.4% |
| 2022 | 0.38x | CN¥60.12 Million | CN¥156.38 Million | CN¥60.12 Million | ▲ +179.0% |
| 2021 | 0.14x | CN¥16.29 Million | CN¥118.25 Million | CN¥15.66 Million | — |